All Type of News
MFDS advises additional warnings to 9 antidepressants
Pharmaceutical companies producing antidepressants must include a warning with their products that state the drugs may develop a life-threating serotonin syndrome in patients receiving a concomitant administration wit...
Dong-A ST partners with Huons to market new premature ejaculation treatment
Dong-A ST, an affiliated company of Dong-A Socio Holdings, said Friday that it has entered into a license and distribution agreement with Huons, a local bio-tech firm, to acquire exclusive distribution rights to Huon'...
Leading drug firms’ scions emerge as rich stockholders
Stocks of major pharmaceutical firms’ owners are being handed down from generation to generation, making grandsons and granddaughters more prosperous.
In an assessment of offspring in pharmaceutical firms, Yakup.co...
National insurance to expand coverage for more cancer drugs
The Health Insurance Review and Assessment Service (HIRA) said Thursday that the government will move to expand coverage of new anticancer medicines by its national health insurance program as the Ministry of Health a...
KDLC to set up joint logistics warehouse in Opo
The Korea Drug Logistics Cooperative (KDLC) unveiled its plan to rent a joint logistics warehouse of about 360 pyung (1 pyung = 3.3 square meters) in Opo, Gyunggi Province until the end of June at the latest.
The w...
Infopia to export blood glucose monitoring system to US
A Korean healthcare company, Infopia Co., said Thursday it has signed an agreement a leading U.S. drug and medical device distributor to export its biosensors for monitoring blood glucose to the US for the next five y...
RNL Bio aims to conduct Phase IIb trials for RNL-JointStem for osteoarthritis in US
RNL Bio, a stem cell biotechnology company, said Thursday that it has filed an Investigational New Drug application (IND) with the US Food and Drug Administration to start phase IIb clinical trials with its adipose-de...
Leader board of drug manufacturers in first quarter?
The local pharmaceutical industry is undergoing a major transformation in the first-quarter reshuffling of the leader board of drug manufacturers.
Dong-A Pharmaceutical kept its number 1 ranking in terms of revenue...
Roche Korea seeking ethics management
Many say Illegal rebates are still commonly practiced in the Korean medical industry here, but Roche Korea has spared no effort to follow its headquarters’ stringent ethics management guideline, according to Svend Pet...
Three companies to expand market presence of new diabetes combo agent
Three drug makers – Boehringer Ingelheim Korea, Lilly Korea and Yuhah Corp. – announced Tuesday that they will expand the market presence of Tranjenta Duo, a combination tablet of dipeptidyl peptidase-4 (DPP-4) inhibi...
